Disease Landscape and Forecast Insights

Report November 14, 2023

Restless Legs Syndrome – Epidemiology – Mature Markets Data

Clarivate Epidemiology’s coverage of restless legs syndrome (RLS) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States,…

north_east

Report October 9, 2023

Alzheimer’s Disease – Epidemiology – Asia-Pacific

Clarivate Epidemiology’s coverage of Alzheimer’s disease (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the lifetime prevalence of AD…

north_east

Report October 9, 2023

Alzheimer’s Disease – Epidemiology – Europe

Clarivate Epidemiology’s coverage of Alzheimer’s disease (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the lifetime prevalence of AD…

north_east

Report October 9, 2023

Alzheimer’s Disease – Epidemiology – Americas

Clarivate Epidemiology’s coverage of Alzheimer’s disease (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the lifetime prevalence of AD…

north_east

Report October 9, 2023

Alzheimer’s Disease – Epidemiology – Emerging Markets

Clarivate Epidemiology’s coverage of Alzheimer’s disease (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the lifetime prevalence of AD…

north_east

Report October 9, 2023

Alzheimer’s Disease – Epidemiology – Middle East & Africa

Clarivate Epidemiology’s coverage of Alzheimer’s disease (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the lifetime prevalence of AD…

north_east

Report October 3, 2023

Myasthenia Gravis – Epidemiology – Mature Markets

Clarivate Epidemiology’s coverage of myasthenia gravis (MG) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of MG for each…

north_east

Report October 3, 2023

Myasthenia Gravis – Epidemiology – Epidemiology Dashboard

Clarivate Epidemiology’s coverage of myasthenia gravis comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the diagnosed prevalence of the…

north_east

Report October 3, 2023

Myasthenia Gravis – Epidemiology – Extrapolated Worldwide Coverage

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key myasthenia gravis patient populations, covering 171 countries and…

north_east

Report July 18, 2023

Multiple Sclerosis – Geographic Focus: China – Multiple Sclerosis: China In-Depth (China)

Multiple sclerosis (MS), a chronic immune-mediated disease of the nervous system, is classified as a rare disease in China because of its low prevalence in that country. Traditionally, MS patients…

north_east

Report July 7, 2023

Parkinson’s Disease – Current Treatment – Current Treatment: Physician Insights -Parkinson’s Disease (US)

The treatment of Parkinson’s disease (PD) requires personalized care, a high degree of polypharmacy, and frequent adjustments to achieve symptom control throughout the disease course…

north_east

Report June 15, 2023

Alzheimer’s Disease – Epidemiology – Mature Markets

Clarivate Epidemiology’s coverage of Alzheimer’s disease (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the lifetime prevalence of AD…

north_east

Product logins

Disease Landscape and Forecast Insights

Restless Legs Syndrome – Epidemiology – Mature Markets Data

Alzheimer’s Disease – Epidemiology – Asia-Pacific

Alzheimer’s Disease – Epidemiology – Europe

Alzheimer’s Disease – Epidemiology – Americas

Alzheimer’s Disease – Epidemiology – Emerging Markets

Alzheimer’s Disease – Epidemiology – Middle East & Africa

Myasthenia Gravis – Epidemiology – Mature Markets

Myasthenia Gravis – Epidemiology – Epidemiology Dashboard

Myasthenia Gravis – Epidemiology – Extrapolated Worldwide Coverage

Multiple Sclerosis – Geographic Focus: China – Multiple Sclerosis: China In-Depth (China)

Parkinson’s Disease – Current Treatment – Current Treatment: Physician Insights -Parkinson’s Disease (US)

Alzheimer’s Disease – Epidemiology – Mature Markets

Follow us

Contact us